Linda L. Carpenter - Publications

Affiliations: 
Psychiatry and Human Behavior Alpert Medical School at Brown University, Providence, RI, United States 
Area:
Neurobiology of mood disorders, psychoneuroendocrinology
Website:
http://research.brown.edu/research/profile.php?id=1100923839&r=1

180 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Sackeim HA, Aaronson ST, Carpenter LL, Hutton TM, Pages K, Lucas L, Chen B. When to hold and when to fold: Early prediction of nonresponse to transcranial magnetic stimulation in major depressive disorder. Brain Stimulation. 17: 272-282. PMID 38458381 DOI: 10.1016/j.brs.2024.02.019  0.347
2024 Gonsalves MA, White TL, Barredo J, DeMayo MM, DeLuca E, Harris AD, Carpenter LL. Cortical glutamate, Glx, and total N-acetylaspartate: potential biomarkers of repetitive transcranial magnetic stimulation treatment response and outcomes in major depression. Translational Psychiatry. 14: 5. PMID 38184652 DOI: 10.1038/s41398-023-02715-9  0.317
2023 Hutton TM, Aaronson ST, Carpenter LL, Pages K, Krantz D, Lucas L, Chen B, Sackeim HA. Dosing transcranial magnetic stimulation in major depressive disorder: Relations between number of treatment sessions and effectiveness in a large patient registry. Brain Stimulation. 16: 1510-1521. PMID 37827360 DOI: 10.1016/j.brs.2023.10.001  0.369
2023 Hutton TM, Aaronson ST, Carpenter LL, Pages K, West WS, Kraemer C, Sackeim HA. The Anxiolytic and Antidepressant Effects of Transcranial Magnetic Stimulation in Patients With Anxious Depression. The Journal of Clinical Psychiatry. 84. PMID 36630648 DOI: 10.4088/JCP.22m14571  0.372
2022 Gonsalves MA, White TL, Barredo J, Fukuda AM, Joyce HE, Harris AD, Carpenter LL. Repetitive Transcranial Magnetic Stimulation-Associated Changes in Neocortical Metabolites in Major Depression: A Systematic Review. Neuroimage. Clinical. 35: 103049. PMID 35738081 DOI: 10.1016/j.nicl.2022.103049  0.326
2022 Cosmo C, Berlow YA, Grisanzio KA, Fleming SL, Rashed Ahmed AP, Brennan MC, Carpenter LL, Philip NS. Transdiagnostic Symptom Subtypes to Predict Response to Therapeutic Transcranial Magnetic Stimulation in Major Depressive Disorder and Posttraumatic Stress Disorder. Journal of Personalized Medicine. 12. PMID 35207712 DOI: 10.3390/jpm12020224  0.341
2022 Wilson S, Croarkin PE, Aaronson ST, Carpenter LL, Cochran M, Stultz DJ, Kozel FA. Systematic review of preservation TMS that includes continuation, maintenance, relapse-prevention, and rescue TMS. Journal of Affective Disorders. 296: 79-88. PMID 34592659 DOI: 10.1016/j.jad.2021.09.040  0.308
2021 Cavallero F, Gold MC, Tirrell E, Kokdere F, Donachie N, Steinfink D, Kriske J, Carpenter LL. Audio-Guided Mindfulness Meditation During Transcranial Magnetic Stimulation Sessions for the Treatment of Major Depressive Disorder: A Pilot Feasibility Study. Frontiers in Psychology. 12: 678911. PMID 34484035 DOI: 10.3389/fpsyg.2021.678911  0.371
2021 Fukuda AM, Kang JWD, Gobin AP, Tirrell E, Kokdere F, Carpenter LL. Effects of transcranial magnetic stimulation on anhedonia in treatment resistant major depressive disorder. Brain and Behavior. PMID 34453491 DOI: 10.1002/brb3.2329  0.356
2020 Franzen AD, Lam TT, Williams KR, Nairn AC, Duman RS, Sathyanesan M, Kumar V, Carpenter LL, Newton SS. Cerebrospinal fluid proteome evaluation in major depressive disorder by mass spectrometry. Bmc Psychiatry. 20: 481. PMID 32998701 DOI: 10.1186/s12888-020-02874-9  0.302
2020 Fukuda AM, Hindley LE, Kang JWD, Tirrell E, Tyrka AR, Ayala A, Carpenter LL. Peripheral vascular endothelial growth factor changes after transcranial magnetic stimulation in treatment-resistant depression. Neuroreport. PMID 32956213 DOI: 10.1097/Wnr.0000000000001523  0.368
2020 Sackeim HA, Aaronson ST, Carpenter LL, Hutton TM, Mina M, Pages K, Verdoliva S, West WS. Clinical outcomes in a large registry of patients with major depressive disorder treated with Transcranial Magnetic Stimulation. Journal of Affective Disorders. 277: 65-74. PMID 32799106 DOI: 10.1016/J.Jad.2020.08.005  0.396
2020 Kokdere F, Tirrell E, Fukuda AM, Gobin AP, Kavanaugh B, Price LH, Carpenter LL. Do Deviations from the 5 Sessions per Week Schedule Impact Outcomes of Transcranial Magnetic Stimulation for Major Depressive Disorder? Brain Stimulation. PMID 32768691 DOI: 10.1016/J.Brs.2020.08.001  0.432
2020 Dichtel LE, Carpenter LL, Nyer M, Mischoulon D, Kimball A, Deckersbach T, Dougherty DD, Schoenfeld DA, Fisher L, Cusin C, Dording C, Trinh NH, Pedrelli P, Yeung A, Farabaugh A, et al. Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study. The American Journal of Psychiatry. appiajp202019080844. PMID 32660299 DOI: 10.1176/Appi.Ajp.2020.19080844  0.427
2020 Zandvakili A, Barredo J, Swearingen HR, Aiken EM, Berlow YA, Greenberg BD, Carpenter LL, Philip NS. Mapping PTSD symptoms to brain networks: a machine learning study. Translational Psychiatry. 10: 195. PMID 32555146 DOI: 10.1038/S41398-020-00879-2  0.306
2020 Dwyer JB, Aftab A, Widge A, Rodriguez CI, Carpenter LL, Nemeroff CB, Kalin NH. Hormonal Treatments for Major Depressive Disorder: State of the Art. The American Journal of Psychiatry. appiajp202019080848. PMID 32456504 DOI: 10.1176/Appi.Ajp.2020.19080848  0.44
2020 Ridout KK, Coe JL, Parade SH, Marsit CJ, Kao HT, Porton B, Carpenter LL, Price LH, Tyrka AR. Molecular markers of neuroendocrine function and mitochondrial biogenesis associated with early life stress. Psychoneuroendocrinology. 116: 104632. PMID 32199200 DOI: 10.1016/J.Psyneuen.2020.104632  0.302
2020 Dichtel LE, Carpenter LL, Nyer M, Mischoulon D, Kimball A, Deckersbach T, Dougherty DD, Schoenfeld D, Fisher L, Cusin C, Trinh N, Pedrelli P, Yeung A, Farabaugh A, Papakostas G, et al. SAT-737 Low-Dose Testosterone Augmentation for Treatment-Resistant Depression in Women: An 8-Week, Two-Site, Randomized, Placebo-Controlled Study Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.081  0.405
2020 Tirrell E, Cavallero F, Kokdere F, Gold M, Donachie N, Steinfink D, Kriske J, Carpenter LL. Audio-Guided Mindfulness Meditation During TMS Sessions for the Treatment of Major Depressive Disorder (MDD): A Feasibility Pilot Study Brain Stimulation. 13: 1846. DOI: 10.1016/j.brs.2020.06.031  0.367
2020 Fukuda AM, Diane Kang JW, Kokdere F, Tirrell E, Carpenter LL. Anhedonia in Major Depressive Disorder: Can it be the Chicken AND the Egg for Transcranial Magnetic Stimulation? Brain Stimulation. 13: 1844. DOI: 10.1016/j.brs.2020.06.023  0.333
2019 Garnaat SL, Fukuda AM, Yuan S, Carpenter LL. Identification of Clinical Features and Biomarkers that may inform a Personalized Approach to rTMS for Depression. Personalized Medicine in Psychiatry. 17: 4-16. PMID 33954269 DOI: 10.1016/j.pmip.2019.09.001  0.328
2019 Zandvakili A, Berlow YA, Carpenter LL, Philip NS. Transcranial Direct Current Stimulation in Psychiatry: What Psychiatrists Need to Know. Focus (American Psychiatric Publishing). 17: 44-49. PMID 31975960 DOI: 10.1176/appi.focus.20180029  0.328
2019 Beck QM, Tirrell E, Fukuda AM, Kokdere F, Carpenter LL. Can early treatment response serve as a predictor of antidepressant outcome of repetitive Transcranial Magnetic Stimulation? Brain Stimulation. PMID 31882372 DOI: 10.1016/J.Brs.2019.12.002  0.339
2019 Kavanaugh BC, Cancilliere MK, Fryc A, Tirrell E, Oliveira J, Oberman LM, Wexler BE, Carpenter LL, Spirito A. Measurement of executive functioning with the National Institute of Health Toolbox and the association to anxiety/depressive symptomatology in childhood/adolescence. Child Neuropsychology : a Journal On Normal and Abnormal Development in Childhood and Adolescence. 1-16. PMID 31876232 DOI: 10.1080/09297049.2019.1708295  0.429
2019 Yuan S, Tirrell E, Gobin AP, Carpenter LL. Effect of Previous Electroconvulsive Therapy on Subsequent Response to Transcranial Magnetic Stimulation for Major Depressive Disorder. Neuromodulation : Journal of the International Neuromodulation Society. PMID 31588659 DOI: 10.1111/Ner.13046  0.453
2019 Barredo J, Bellone JA, Edwards M, Carpenter LL, Correia S, Philip NS. White matter integrity and functional predictors of response to repetitive transcranial magnetic stimulation for posttraumatic stress disorder and major depression. Depression and Anxiety. PMID 31475432 DOI: 10.1002/Da.22952  0.436
2019 Bushnell DM, McCarrier KP, Bush EN, Abraham L, Jamieson C, McDougall F, Trivedi MH, Thase ME, Carpenter L, Coons SJ. Symptoms of Major Depressive Disorder Scale: Performance of a Novel Patient-Reported Symptom Measure. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 22: 906-915. PMID 31426932 DOI: 10.1016/J.Jval.2019.02.010  0.451
2019 Corlier J, Carpenter LL, Wilson AC, Tirrell E, Gobin AP, Kavanaugh B, Leuchter AF. The relationship between individual alpha peak frequency and clinical outcome with repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD). Brain Stimulation. PMID 31378603 DOI: 10.1016/J.Brs.2019.07.018  0.438
2019 Fukuda AM, Tirrell E, Gobin AP, Carpenter LL. Repetitive Transcranial Magnetic Stimulation for depression relapse or recurrence: Naturalistic retreatment series outcomes. Brain Stimulation. PMID 31266723 DOI: 10.1016/J.Brs.2019.06.016  0.389
2019 Zandvakili A, Philip NS, Jones SR, Tyrka AR, Greenberg BD, Carpenter LL. Use of machine learning in predicting clinical response to transcranial magnetic stimulation in comorbid posttraumatic stress disorder and major depression: A resting state electroencephalography study. Journal of Affective Disorders. 252: 47-54. PMID 30978624 DOI: 10.1016/J.Jad.2019.03.077  0.41
2019 Berlow YA, Zandvakili A, Carpenter LL, Philip NS. Transcranial direct current stimulation for unipolar depression and risk of treatment emergent mania: An updated meta-analysis. Brain Stimulation. PMID 30926260 DOI: 10.1016/J.Brs.2019.03.025  0.407
2019 Widge AS, Rodriguez CI, Carpenter LL, Kalin NH, McDonald W, Nemeroff CB. EEG Biomarkers for Treatment Response Prediction in Major Depressive Illness. The American Journal of Psychiatry. 176: 82. PMID 30848947 DOI: 10.1176/Appi.Ajp.2018.1760101  0.406
2019 Barredo J, Aiken E, van 't Wout-Frank M, Greenberg BD, Carpenter LL, Philip NS. Neuroimaging Correlates of Suicidality in Decision-Making Circuits in Posttraumatic Stress Disorder. Frontiers in Psychiatry. 10: 44. PMID 30809160 DOI: 10.3389/Fpsyt.2019.00044  0.33
2019 Voigt J, Carpenter L, Leuchter A. A systematic literature review of the clinical efficacy of repetitive transcranial magnetic stimulation (rTMS) in non-treatment resistant patients with major depressive disorder. Bmc Psychiatry. 19: 13. PMID 30621636 DOI: 10.1186/S12888-018-1989-Z  0.371
2019 Dichtel L, Kimball A, Nyer M, Mischoulon D, Fisher L, Cusin C, Dording C, Trinh N, Yeung A, Rao E, Pinna G, Carpenter L, Fava M, Miller K. MON-449 Serum Neuroactive Steroid Levels in Postmenopausal Women with Treatment-Resistant Major Depressive Disorder Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Mon-449  0.396
2019 Garnaat SL, Fukuda AM, Yuan S, Carpenter LL. Identification of clinical features and biomarkers that may inform a personalized approach to rTMS for depression Personalized Medicine in Psychiatry. 17: 4-16. DOI: 10.1016/J.Pmip.2019.09.001  0.436
2019 Carpenter L, Tirrell E, Gobin P, Kavanaugh B, Corlier J, Wilson A. Individual alpha frequency proximity to stimulation frequency is associated with clinical outcome during 10 Hz repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD) Brain Stimulation. 12: 543-544. DOI: 10.1016/J.Brs.2018.12.794  0.396
2019 Berlow Y, Vakili AZ, Carpenter L, Philip N. S107. Transcranial Direct Current Stimulation for Depression and Risk of Treatment Emergent Mania: An Updated Meta-Analysis Biological Psychiatry. 85: S339. DOI: 10.1016/J.Biopsych.2019.03.858  0.399
2018 Petrosino NJ, Zandvakili A, Carpenter LL, Philip NS. Pilot Testing of Peak Alpha Frequency Stability During Repetitive Transcranial Magnetic Stimulation. Frontiers in Psychiatry. 9: 605. PMID 30515110 DOI: 10.3389/Fpsyt.2018.00605  0.417
2018 Philip NS, Leuchter AF, Cook IA, Massaro J, Goethe JW, Carpenter LL. Predictors of response to synchronized transcranial magnetic stimulation for major depressive disorder. Depression and Anxiety. PMID 30480860 DOI: 10.1002/Da.22862  0.437
2018 Bennett E, Almeida JRC, Carpenter LL. Do bipolar disorder soft signs impact outcomes following Transcranial Magnetic Stimulation (TMS) therapy for depression? Journal of Affective Disorders. 245: 237-240. PMID 30414554 DOI: 10.1016/J.Jad.2018.10.367  0.456
2018 Widge AS, Bilge MT, Montana R, Chang W, Rodriguez CI, Deckersbach T, Carpenter LL, Kalin NH, Nemeroff CB. Electroencephalographic Biomarkers for Treatment Response Prediction in Major Depressive Illness: A Meta-Analysis. The American Journal of Psychiatry. appiajp201817121358. PMID 30278789 DOI: 10.1176/Appi.Ajp.2018.17121358  0.413
2018 Laferton JAC, Vijapura S, Baer L, Clain AJ, Cooper A, Papakostas G, Price LH, Carpenter LL, Tyrka AR, Fava M, Mischoulon D. Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major Depression. Frontiers in Psychiatry. 9: 424. PMID 30245644 DOI: 10.3389/Fpsyt.2018.00424  0.428
2018 Welch ES, Weigand A, Hooker JE, Philip NS, Tyrka AR, Press DZ, Carpenter LL. Feasibility of Computerized Cognitive-Behavioral Therapy Combined With Bifrontal Transcranial Direct Current Stimulation for Treatment of Major Depression. Neuromodulation : Journal of the International Neuromodulation Society. PMID 30153360 DOI: 10.1111/Ner.12807  0.38
2018 Garnaat SL, Yuan S, Wang H, Philip NS, Carpenter LL. Updates on Transcranial Magnetic Stimulation Therapy for Major Depressive Disorder. The Psychiatric Clinics of North America. 41: 419-431. PMID 30098655 DOI: 10.1016/J.Psc.2018.04.006  0.453
2018 Russo GB, Tirrell E, Busch A, Carpenter LL. Behavioral activation therapy during transcranial magnetic stimulation for major depressive disorder. Journal of Affective Disorders. 236: 101-104. PMID 29723763 DOI: 10.1016/J.Jad.2018.04.108  0.445
2018 Zeier Z, Carpenter LL, Kalin NH, Rodriguez CI, McDonald WM, Widge AS, Nemeroff CB. Clinical Implementation of Pharmacogenetic Decision Support Tools for Antidepressant Drug Prescribing. The American Journal of Psychiatry. appiajp201817111282. PMID 29690793 DOI: 10.1176/Appi.Ajp.2018.17111282  0.327
2018 Carpenter LL, Conelea C, Tyrka AR, Welch ES, Greenberg BD, Price LH, Niedzwiecki M, Yip AG, Barnes J, Philip NS. 5 Hz Repetitive transcranial magnetic stimulation for posttraumatic stress disorder comorbid with major depressive disorder. Journal of Affective Disorders. 235: 414-420. PMID 29677606 DOI: 10.1016/J.Jad.2018.04.009  0.472
2018 Kavanaugh BC, Aaronson ST, Clarke GN, Holtzheimer PE, Johnson CW, McDonald WM, Schneider MB, Carpenter LL. Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation with a 2-Coil Device in Treatment-Resistant Major Depressive Disorder. The Journal of Ect. PMID 29613944 DOI: 10.1097/Yct.0000000000000494  0.419
2018 Philip NS, Barredo J, Aiken E, Carpenter LL. Neuroimaging Mechanisms of Therapeutic Transcranial Magnetic Stimulation for Major Depressive Disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 3: 211-222. PMID 29486862 DOI: 10.1016/J.Bpsc.2017.10.007  0.426
2018 Yuan S, Tirrell E, Desrochers N, Polly Gobin A, Carpenter LL. Does history of previous ECT treatment affect responsiveness of MDD patients to TMS? Brain Stimulation. 11: e12-e13. DOI: 10.1016/J.Brs.2018.07.014  0.342
2018 Wang H, Carpenter L. S93. Concurrent Antidepressant Use is Not Associated with Different rTMS Treatment Outcomes for Major Depressive Disorder in a Sham-Controlled Trial Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.984  0.433
2018 Yuan S, Tirrell E, Carpenter L. S155. The Effect of Previous ECT Treatment on Responsiveness of MDD Patients to rTMS Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.1047  0.326
2017 Voigt J, Carpenter L, Leuchter A. Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients - A lifetime analysis. Plos One. 12: e0186950. PMID 29073256 DOI: 10.1371/Journal.Pone.0186950  0.445
2017 Philip NS, Barredo J, van 't Wout-Frank M, Tyrka AR, Price LH, Carpenter LL. Network Mechanisms of Clinical Response to Transcranial Magnetic Stimulation in Posttraumatic Stress Disorder and Major Depressive Disorder. Biological Psychiatry. PMID 28886760 DOI: 10.1016/J.Biopsych.2017.07.021  0.454
2017 Conelea CA, Philip NS, Yip AG, Barnes JL, Niedzwiecki MJ, Greenberg BD, Tyrka AR, Carpenter LL. Response to Letter to the Editor regarding "Transcranial magnetic stimulation for treatment-resistant depression: Naturalistic outcomes for younger versus older patients". Journal of Affective Disorders. PMID 28826888 DOI: 10.1016/J.Jad.2017.08.033  0.412
2017 Carpenter LL, Aaronson ST, Clarke GN, Holtzheimer PE, Johnson CW, McDonald WM, Stannard EL, Schneider MB. rTMS with a two-coil array: Safety and efficacy for treatment resistant major depressive disorder. Brain Stimulation. PMID 28642024 DOI: 10.1016/J.Brs.2017.06.003  0.421
2017 McClintock SM, Reti IM, Carpenter LL, McDonald WM, Dubin M, Taylor SF, Cook IA, O'Reardon J, Husain MM, Wall C, Krystal AD, Sampson SM, Morales O, Nelson BG, Latoussakis V, et al. Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression. The Journal of Clinical Psychiatry. PMID 28541649 DOI: 10.4088/Jcp.16Cs10905  0.447
2017 Conelea CA, Philip NS, Yip AG, Barnes JL, Niedzwiecki MJ, Greenberg BD, Tyrka AR, Carpenter LL. Transcranial magnetic stimulation for treatment-resistant depression: Naturalistic treatment outcomes for younger versus older patients. Journal of Affective Disorders. 217: 42-47. PMID 28388464 DOI: 10.1016/J.Jad.2017.03.063  0.415
2017 Yip AG, George MS, Tendler A, Roth Y, Zangen A, Carpenter LL. 61% of unmedicated treatment resistant depression patients who did not respond to acute TMS treatment responded after four weeks of twice weekly deep TMS in the Brainsway pivotal trial. Brain Stimulation. PMID 28330592 DOI: 10.1016/J.Brs.2017.02.013  0.343
2017 Philip NS, Nelson BG, Frohlich F, Lim KO, Widge AS, Carpenter LL. Low-Intensity Transcranial Current Stimulation in Psychiatry. The American Journal of Psychiatry. appiajp201716090996. PMID 28231716 DOI: 10.1176/Appi.Ajp.2017.16090996  0.391
2017 Vakili AZ, Philip NS, Carpenter LL, Greenberg BD. Changes in EEG signal after 5-Hz Dorsolateral Prefrontal cortex (DLPFC) Transcranial Magnetic Stimulation in patients with Comorbid Posttraumatic Stress Disorder and Major Depression Brain Stimulation. 10: e28. DOI: 10.1016/J.Brs.2017.04.030  0.43
2017 Leuchter A, Bissett J, Manberg P, Carpenter L, Massaro J, George M. The relationship between the individual alpha frequency (IAF) and response to synchronized transcranial magnetic stimulation (sTMS) for treatment of major depressive disorder (MDD) Brain Stimulation. 10: 492. DOI: 10.1016/J.Brs.2017.01.439  0.428
2017 Philip N, Barredo J, v 'ant Wout M, Almeida J, Tyrka A, Price L, Carpenter L. Network mechanisms of clinical response to TMS in Posttraumatic stress and major depressive disorders Brain Stimulation. 10: 356. DOI: 10.1016/J.Brs.2017.01.046  0.444
2017 Philip N, Conelea C, Yip A, Barnes J, Niedzwiecki M, Greenberg B, Tyrka A, Carpenter L. 170. 5 Hz Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder Comorbid with Major Depressive Disorder Biological Psychiatry. 81: S70-S71. DOI: 10.1016/J.Biopsych.2017.02.183  0.457
2017 Vakili AZ, Philip N, Carpenter L, Greenberg B. 132. EEG Signal after 5-Hz Transcranial Magnetic Stimulation in Patients with Comorbid Posttraumatic Stress Disorder and Major Depression Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.144  0.452
2017 Philip N, Barredo J, Wout Mv׳, Almeida J, Tyrka A, Price L, Carpenter L. 101. Network Mechanisms of Clinical Response to Transcranial Magnetic Stimulation in Posttraumatic Stress and Major Depressive Disorders Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.113  0.452
2016 Kubu CS, Brelje T, Butters MA, Deckersbach T, Malloy P, Moberg P, Tröster AI, Williamson E, Baltuch GH, Bhati MT, Carpenter LL, Dougherty DD, Howland RH, Rezai AR, Malone DA. Cognitive outcome after ventral capsule/ventral striatum stimulation for treatment-resistant major depression. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27659923 DOI: 10.1136/Jnnp-2016-313803  0.421
2016 Tyrka AR, Parade SH, Welch ES, Ridout KK, Price LH, Marsit C, Philip NS, Carpenter LL. Methylation of the leukocyte glucocorticoid receptor gene promoter in adults: associations with early adversity and depressive, anxiety and substance-use disorders. Translational Psychiatry. 6: e848. PMID 27378548 DOI: 10.1038/Tp.2016.112  0.417
2016 Philip NS, Dunner DL, Dowd SM, Aaronson ST, Brock DG, Carpenter LL, Demitrack MA, Hovav S, Janicak PG, George MS. Erratum to "Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study" [Brain Stimulation 9 (2016) 251-257]. Brain Stimulation. 9: 639. PMID 27320180 DOI: 10.1016/J.Brs.2016.03.015  0.375
2016 Philip NS, Tyrka AR, Albright SE, Sweet LH, Almeida J, Price LH, Carpenter LL. Early life stress predicts thalamic hyperconnectivity: A transdiagnostic study of global connectivity. Journal of Psychiatric Research. 79: 93-100. PMID 27214526 DOI: 10.1016/J.Jpsychires.2016.05.003  0.338
2016 Philip NS, Ridout SJ, Albright SE, Sanchez G, Carpenter LL. 5-Hz Transcranial Magnetic Stimulation for Comorbid Posttraumatic Stress Disorder and Major Depression. Journal of Traumatic Stress. PMID 26748883 DOI: 10.1002/Jts.22065  0.485
2015 Philip NS, Dunner DL, Dowd SM, Aaronson ST, Brock DG, Carpenter LL, Demitrack MA, Hovav S, Janicak PG, George MS. Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study. Brain Stimulation. PMID 26708778 DOI: 10.1016/J.Brs.2015.11.007  0.446
2015 Newport DJ, Carpenter LL, McDonald WM, Potash JB, Tohen M, Nemeroff CB. Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression. The American Journal of Psychiatry. 172: 950-66. PMID 26423481 DOI: 10.1176/Appi.Ajp.2015.15040465  0.341
2015 Philip NS, Carpenter SL, Ridout SJ, Sanchez G, Albright SE, Tyrka AR, Price LH, Carpenter LL. 5Hz Repetitive transcranial magnetic stimulation to left prefrontal cortex for major depression. Journal of Affective Disorders. 186: 13-7. PMID 26210705 DOI: 10.1016/J.Jad.2014.12.024  0.394
2015 Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, Thase ME, Krystal AD, Philip NS, Bhati MT, Burke WJ, Howland RH, Sheline YI, Aaronson ST, Iosifescu DV, et al. Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression. Brain Stimulation. 8: 787-94. PMID 26143022 DOI: 10.1016/J.Brs.2015.05.005  0.404
2015 Sarris J, Price LH, Carpenter LL, Tyrka AR, Ng CH, Papakostas GI, Jaeger A, Fava M, Mischoulon D. Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial. Pharmacopsychiatry. 48: 141-4. PMID 26011569 DOI: 10.1055/S-0035-1549928  0.415
2015 Tyrka AR, Carpenter LL, Kao HT, Porton B, Philip NS, Ridout SJ, Ridout KK, Price LH. Association of telomere length and mitochondrial DNA copy number in a community sample of healthy adults. Experimental Gerontology. 66: 17-20. PMID 25845980 DOI: 10.1016/J.Exger.2015.04.002  0.359
2015 Ridout SJ, Ridout KK, Kao HT, Carpenter LL, Philip NS, Tyrka AR, Price LH. Telomeres, early-life stress and mental illness. Advances in Psychosomatic Medicine. 34: 92-108. PMID 25832516 DOI: 10.1159/000369088  0.334
2015 Philip N, Dowd S, Dunner D, Aaronson S, Brock D, Carpenter L, Demitrack M, Janicak P, George M. Randomized pilot study of two maintenance strategies of NeuroStar Transcranial Magnetic Stimulation in patients with major depression F1000research. 6. DOI: 10.7490/F1000Research.1098068.1  0.413
2015 Brock DG, Philip NS, Dunner DL, Dowd SM, Aaronson ST, Carpenter LL, Demitrack MA, Janicak PG, George MS. A Randomized Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients with Major Depression Brain Stimulation. 8: 429. DOI: 10.1016/J.Brs.2015.01.368  0.413
2015 Leuchter AF, Phillips B, Jin Y, Cook IA, Feifel D, Goethe J, Husain M, Carpenter L, Thase M, Krystal A, Burke W, Howland R, Sheline Y, Jain R, Aaronson S, et al. Safety and Efficacy of Synchronized Transcranial Magnetic Stimulation for the Treatment of Major Depressive Disorder Brain Stimulation. 8: 404. DOI: 10.1016/J.Brs.2015.01.287  0.435
2014 Dougherty DD, Rezai AR, Carpenter LL, Howland RH, Bhati MT, O'Reardon JP, Eskandar EN, Baltuch GH, Machado AD, Kondziolka D, Cusin C, Evans KC, Price LH, Jacobs K, Pandya M, et al. A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression. Biological Psychiatry. PMID 25726497 DOI: 10.1016/J.Biopsych.2014.11.023  0.367
2014 Dunner DL, Aaronson ST, Sackeim HA, Janicak PG, Carpenter LL, Boyadjis T, Brock DG, Bonneh-Barkay D, Cook IA, Lanocha K, Solvason HB, Demitrack MA. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. The Journal of Clinical Psychiatry. 75: 1394-401. PMID 25271871 DOI: 10.4088/Jcp.13M08977  0.41
2014 Philip NS, Carpenter SL, Carpenter LL. Safe use of repetitive transcranial magnetic stimulation in patients with implanted vagus nerve stimulators. Brain Stimulation. 7: 608-12. PMID 24794163 DOI: 10.1016/J.Brs.2014.04.001  0.335
2014 Philip NS, Valentine TR, Sweet LH, Tyrka AR, Price LH, Carpenter LL. Early life stress impacts dorsolateral prefrontal cortex functional connectivity in healthy adults: informing future studies of antidepressant treatments. Journal of Psychiatric Research. 52: 63-9. PMID 24513500 DOI: 10.1016/J.Jpsychires.2014.01.014  0.378
2014 Mischoulon D, Price LH, Carpenter LL, Tyrka AR, Papakostas GI, Baer L, Dording CM, Clain AJ, Durham K, Walker R, Ludington E, Fava M. A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder. The Journal of Clinical Psychiatry. 75: 370-6. PMID 24500245 DOI: 10.4088/Jcp.13M08591  0.409
2014 Janicak PG, Carpenter L. The efficacy of transcranial magnetic stimulation for major depression: A review of the evidence Psychiatric Annals. 44: 284-292. DOI: 10.3928/00485713-20140609-06  0.402
2013 Philip NS, Kuras YI, Valentine TR, Sweet LH, Tyrka AR, Price LH, Carpenter LL. Regional homogeneity and resting state functional connectivity: associations with exposure to early life stress. Psychiatry Research. 214: 247-53. PMID 24090510 DOI: 10.1016/J.Pscychresns.2013.07.013  0.326
2013 Janicak PG, Dunner DL, Aaronson ST, Carpenter LL, Boyadjis TA, Brock DG, Cook IA, Lanocha K, Solvason HB, Bonneh-Barkay D, Demitrack MA. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice. Cns Spectrums. 18: 322-32. PMID 23895940 DOI: 10.1017/S1092852913000357  0.432
2013 Tyrka AR, Burgers DE, Philip NS, Price LH, Carpenter LL. The neurobiological correlates of childhood adversity and implications for treatment. Acta Psychiatrica Scandinavica. 128: 434-47. PMID 23662634 DOI: 10.1111/Acps.12143  0.338
2013 Philip NS, Sweet LH, Tyrka AR, Price LH, Carpenter LL, Kuras YI, Clark US, Niaura RS. Early life stress is associated with greater default network deactivation during working memory in healthy controls: a preliminary report. Brain Imaging and Behavior. 7: 204-12. PMID 23269472 DOI: 10.1007/S11682-012-9216-X  0.305
2013 Philip NS, Sweet LH, Tyrka AR, Price LH, Bloom RF, Carpenter LL. Decreased default network connectivity is associated with early life stress in medication-free healthy adults. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 24-32. PMID 23141153 DOI: 10.1016/J.Euroneuro.2012.10.008  0.325
2013 Aaronson ST, Carpenter LL, Conway CR, Reimherr FW, Lisanby SH, Schwartz TL, Moreno FA, Dunner DL, Lesem MD, Thompson PM, Husain M, Vine CJ, Banov MD, Bernstein LP, Lehman RB, et al. Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects. Brain Stimulation. 6: 631-40. PMID 23122916 DOI: 10.1016/J.Brs.2012.09.013  0.425
2013 Price LH, Kao HT, Burgers DE, Carpenter LL, Tyrka AR. Telomeres and early-life stress: an overview. Biological Psychiatry. 73: 15-23. PMID 22831981 DOI: 10.1016/J.Biopsych.2012.06.025  0.354
2013 Philip NS, Valentine TR, Kuras YI, Tyrka AR, Price LH, Carpenter LL. Regional homogeneity and resting state functional connectivity: associations with early life stress F1000research. 4. DOI: 10.7490/F1000Research.1093485.1  0.301
2013 McCarrier K, Martin M, Bushnell D, Abraham L, Bush E, Houle C, Mathews M, Carpenter L, Blum S. Qualitative development and cognitive evaluation of the symptoms of major depressive disorder (s-mdd), a consortium-developed patient reported outcome measure Value in Health. 16: A63. DOI: 10.1016/J.Jval.2013.03.1592  0.403
2012 Carpenter LL, Janicak PG, Aaronson ST, Boyadjis T, Brock DG, Cook IA, Dunner DL, Lanocha K, Solvason HB, Demitrack MA. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety. 29: 587-96. PMID 22689344 DOI: 10.1002/Da.21969  0.448
2012 Carpenter LL, Gawuga CE, Tyrka AR, Price LH. C-reactive protein, early life stress, and wellbeing in healthy adults. Acta Psychiatrica Scandinavica. 126: 402-10. PMID 22681496 DOI: 10.1111/J.1600-0447.2012.01892.X  0.742
2012 Philip NS, Carpenter LL, Tyrka AR, Price LH. The nicotinic acetylcholine receptor as a target for antidepressant drug development. Thescientificworldjournal. 2012: 104105. PMID 22619570 DOI: 10.1100/2012/104105  0.312
2012 Tyrka AR, Walters OC, Price LH, Anderson GM, Carpenter LL. Altered response to neuroendocrine challenge linked to indices of the metabolic syndrome in healthy adults. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Mã©Tabolisme. 44: 543-9. PMID 22549400 DOI: 10.1055/S-0032-1306342  0.369
2012 Tyrka AR, Price LH, Marsit C, Walters OC, Carpenter LL. Childhood adversity and epigenetic modulation of the leukocyte glucocorticoid receptor: preliminary findings in healthy adults. Plos One. 7: e30148. PMID 22295073 DOI: 10.1371/Journal.Pone.0030148  0.319
2012 Hsieh TH, Dhamne SC, Chen JJ, Carpenter LL, Anastasio EM, Pascual-Leone A, Rotenberg A. Minimal heating of aneurysm clips during repetitive transcranial magnetic stimulation. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 123: 1471-3. PMID 22119800 DOI: 10.1016/J.Clinph.2011.10.048  0.312
2012 Philip NS, Sweet LH, Tyrka AR, Price LH, Bloom RF, Carpenter LL. Towards imaging biomarkers of early life stress: decreased resting state default network connectivity F1000research. 3. DOI: 10.7490/F1000Research.1090528.1  0.383
2012 Houle C, Blum S, Carpenter L, Dedios C, Greco N, Thase M, Trivedi M, Martin M, Ramasamy A. PMH40 How do Patients Describe Their Depression? - Incorporating the Patient's Voice Into Instrument Development Value in Health. 15: A341. DOI: 10.1016/J.Jval.2012.08.830  0.368
2012 McCarrier K, Abraham L, Carpenter L, Deal L, Thase M, Trivedi M, Blum S. PMH39 Identifying Disease-Defining Concepts Using Spontaneous and Probed Responses From Semi-Structured Qualitative Interviews in Patients With Major Depressive Disorder Value in Health. 15: A341. DOI: 10.1016/J.Jval.2012.08.829  0.418
2012 Gawuga C, Tyrka A, Price L, Carpenter L. 145. Temporal associations between IL-6 and cortisol production in response to acute psychosocial stress Brain, Behavior, and Immunity. 26: S40. DOI: 10.1016/J.Bbi.2012.07.169  0.334
2011 Carpenter LL, Tyrka AR, Lee JK, Tracy AP, Wilkinson CW, Price LH. A placebo-controlled study of sertraline's effect on cortisol response to the dexamethasone/corticotropin-releasing hormone test in healthy adults. Psychopharmacology. 218: 371-9. PMID 21617914 DOI: 10.1007/S00213-011-2336-Y  0.412
2011 Nugent NR, Tyrka AR, Carpenter LL, Price LH. Gene-environment interactions: early life stress and risk for depressive and anxiety disorders. Psychopharmacology. 214: 175-96. PMID 21225419 DOI: 10.1007/S00213-010-2151-X  0.428
2011 Carpenter LL, Shattuck TT, Tyrka AR, Geracioti TD, Price LH. Effect of childhood physical abuse on cortisol stress response. Psychopharmacology. 214: 367-75. PMID 20838776 DOI: 10.1007/S00213-010-2007-4  0.367
2010 Carpenter LL, Gawuga CE, Tyrka AR, Lee JK, Anderson GM, Price LH. Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2617-23. PMID 20881945 DOI: 10.1038/Npp.2010.159  0.743
2010 Philip NS, Carpenter LL, Tyrka AR, Price LH. Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature. Psychopharmacology. 212: 1-12. PMID 20614106 DOI: 10.1007/S00213-010-1932-6  0.379
2010 Yip AG, Carpenter LL. Transcranial magnetic stimulation for medication-resistant depression. The Journal of Clinical Psychiatry. 71: 502-3. PMID 20409447 DOI: 10.4088/Jcp.10Ac06054Blu  0.383
2010 Schoedl AF, Costa MC, Mari JJ, Mello MF, Tyrka AR, Carpenter LL, Price LH. The clinical correlates of reported childhood sexual abuse: an association between age at trauma onset and severity of depression and PTSD in adults. Journal of Child Sexual Abuse. 19: 156-70. PMID 20390785 DOI: 10.1080/10538711003615038  0.371
2010 Philip NS, Carpenter LL, Tyrka AR, Price LH. Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era. Expert Opinion On Pharmacotherapy. 11: 709-22. PMID 20151847 DOI: 10.1517/14656561003614781  0.4
2010 Tyrka AR, Price LH, Kao HT, Porton B, Marsella SA, Carpenter LL. Childhood maltreatment and telomere shortening: preliminary support for an effect of early stress on cellular aging. Biological Psychiatry. 67: 531-4. PMID 19828140 DOI: 10.1016/J.Biopsych.2009.08.014  0.327
2010 Amin Z, Kanarek K, Krupitsky E, Walderhaug E, Ilomäki R, Blumberg H, Price LH, Bhagwagar Z, Carpenter LL, Tyrka AR, Magnusson A, Landrø NI, Zvartau E, Gelernter J, Epperson CN, et al. A sequencing-based survey of functional APAF1 alleles in a large sample of individuals with affective illness and population controls. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 332-5. PMID 19455599 DOI: 10.1002/Ajmg.B.30984  0.306
2010 Cusin C, Evans KC, Carpenter LL, Greenberg BD, Malone DA, Eskandar E, Dougherty DD. Deep brain stimulation for treatment resistant depression: The role of the ventral capsule/ventral striatum Psychiatric Annals. 40: 477-484. DOI: 10.3928/00485713-20100924-04  0.388
2009 Mello MF, Faria AA, Mello AF, Carpenter LL, Tyrka AR, Price LH. [Childhood maltreatment and adult psychopathology: pathways to hypothalamic-pituitary-adrenal axis dysfunction]. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 31: S41-8. PMID 19967199 DOI: 10.1590/S1516-44462009000600002  0.348
2009 Tyrka AR, Price LH, Gelernter J, Schepker C, Anderson GM, Carpenter LL. Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity. Biological Psychiatry. 66: 681-5. PMID 19596121 DOI: 10.1016/J.Biopsych.2009.05.012  0.37
2009 Carpenter LL, Ross NS, Tyrka AR, Anderson GM, Kelly M, Price LH. Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls. Psychoneuroendocrinology. 34: 1208-13. PMID 19375869 DOI: 10.1016/J.Psyneuen.2009.03.009  0.459
2009 Carpenter LL, Tyrka AR, Ross NS, Khoury L, Anderson GM, Price LH. Effect of childhood emotional abuse and age on cortisol responsivity in adulthood. Biological Psychiatry. 66: 69-75. PMID 19375070 DOI: 10.1016/J.Biopsych.2009.02.030  0.362
2009 Philip NS, Carpenter LL, Tyrka AR, Whiteley LB, Price LH. Varenicline augmentation in depressed smokers: an 8-week, open-label study. The Journal of Clinical Psychiatry. 70: 1026-31. PMID 19323966 DOI: 10.4088/Jcp.08M04441  0.425
2009 Tyrka AR, Wyche MC, Kelly MM, Price LH, Carpenter LL. Childhood maltreatment and adult personality disorder symptoms: influence of maltreatment type. Psychiatry Research. 165: 281-7. PMID 19162332 DOI: 10.1016/J.Psychres.2007.10.017  0.358
2009 Malone DA, Dougherty DD, Rezai AR, Carpenter LL, Friehs GM, Eskandar EN, Rauch SL, Rasmussen SA, Machado AG, Kubu CS, Tyrka AR, Price LH, Stypulkowski PH, Giftakis JE, Rise MT, et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biological Psychiatry. 65: 267-75. PMID 18842257 DOI: 10.1016/J.Biopsych.2008.08.029  0.4
2009 Carpenter LL, Wyche MC, Friehs GM, O'Reardon JP. Electroconvulsive Therapy, Transcranial Magnetic Stimulation, and Vagus Nerve Stimulation for Depression Neuromodulation. 2: 665-676. DOI: 10.1016/B978-0-12-374248-3.00055-0  0.398
2008 Tyrka AR, Wier L, Price LH, Ross NS, Carpenter LL. Childhood parental loss and adult psychopathology: effects of loss characteristics and contextual factors. International Journal of Psychiatry in Medicine. 38: 329-44. PMID 19069576 DOI: 10.2190/Pm.38.3.H  0.341
2008 Greenberg BD, Askland KD, Carpenter LL. The evolution of deep brain stimulation for neuropsychiatric disorders. Frontiers in Bioscience : a Journal and Virtual Library. 13: 4638-48. PMID 18508535 DOI: 10.2741/3029  0.397
2008 Tyrka AR, Wier LM, Price LH, Rikhye K, Ross NS, Anderson GM, Wilkinson CW, Carpenter LL. Cortisol and ACTH responses to the Dex/CRH test: influence of temperament. Hormones and Behavior. 53: 518-25. PMID 18294637 DOI: 10.1016/J.Yhbeh.2007.12.004  0.448
2008 Philip NS, Carpenter LL, Tyrka AR, Price LH. Augmentation of antidepressants with atypical antipsychotics: a review of the current literature. Journal of Psychiatric Practice. 14: 34-44. PMID 18212601 DOI: 10.1097/01.Pra.0000308493.93003.92  0.415
2008 Rikhye K, Tyrka AR, Kelly MM, Gagne GG, Mello AF, Mello MF, Price LH, Carpenter LL. Interplay between childhood maltreatment, parental bonding, and gender effects: impact on quality of life. Child Abuse & Neglect. 32: 19-34. PMID 18082260 DOI: 10.1016/J.Chiabu.2007.04.012  0.333
2008 Carpenter LL, Bayat L, Moreno F, Kling MA, Price LH, Tyrka AR, Kinkead B, Owens MJ, Nemeroff CB. Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy. Psychiatry Research. 157: 123-9. PMID 17976740 DOI: 10.1016/J.Psychres.2007.04.016  0.437
2008 Kelly MM, Tyrka AR, Price LH, Carpenter LL. Sex differences in the use of coping strategies: predictors of anxiety and depressive symptoms. Depression and Anxiety. 25: 839-46. PMID 17603810 DOI: 10.1002/Da.20341  0.405
2008 Kelly MM, Tyrka AR, Anderson GM, Price LH, Carpenter LL. Sex differences in emotional and physiological responses to the Trier Social Stress Test. Journal of Behavior Therapy and Experimental Psychiatry. 39: 87-98. PMID 17466262 DOI: 10.1016/J.Jbtep.2007.02.003  0.355
2007 Park MC, Goldman MA, Carpenter LL, Price LH, Friehs GM. Vagus nerve stimulation for depression: rationale, anatomical and physiological basis of efficacy and future prospects. Acta Neurochirurgica. Supplement. 97: 407-16. PMID 17691329 DOI: 10.1007/978-3-211-33081-4_46  0.45
2007 Grover KE, Carpenter LL, Price LH, Gagne GG, Mello AF, Mello MF, Tyrka AR. The relationship between childhood abuse and adult personality disorder symptoms. Journal of Personality Disorders. 21: 442-7. PMID 17685839 DOI: 10.1521/Pedi.2007.21.4.442  0.369
2007 Carpenter LL, Carvalho JP, Tyrka AR, Wier LM, Mello AF, Mello MF, Anderson GM, Wilkinson CW, Price LH. Decreased adrenocorticotropic hormone and cortisol responses to stress in healthy adults reporting significant childhood maltreatment. Biological Psychiatry. 62: 1080-7. PMID 17662255 DOI: 10.1016/J.Biopsych.2007.05.002  0.42
2007 Mello AF, Juruena MF, Pariante CM, Tyrka AR, Price LH, Carpenter LL, Del Porto JA. [Depression and stress: is there an endophenotype?]. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 29: S13-8. PMID 17546342 DOI: 10.1590/S1516-44462007000500004  0.451
2007 Tyrka AR, Wier LM, Anderson GM, Wilkinson CW, Price LH, Carpenter LL. Temperament and response to the Trier Social Stress Test. Acta Psychiatrica Scandinavica. 115: 395-402. PMID 17430418 DOI: 10.1111/J.1600-0447.2006.00941.X  0.361
2006 Tyrka AR, Mello AF, Mello MF, Gagne GG, Grover KE, Anderson GM, Price LH, Carpenter LL. Temperament and hypothalamic-pituitary-adrenal axis function in healthy adults. Psychoneuroendocrinology. 31: 1036-45. PMID 16908106 DOI: 10.1016/J.Psyneuen.2006.06.004  0.43
2006 DeBattista C, Belanoff J, Glass S, Khan A, Horne RL, Blasey C, Carpenter LL, Alva G. Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression. Biological Psychiatry. 60: 1343-9. PMID 16889757 DOI: 10.1016/J.Biopsych.2006.05.034  0.437
2006 Wier LM, Tavares SB, Tyrka AR, Price LH, Carpenter LL. Levetiracetam-induced depression in a healthy adult. The Journal of Clinical Psychiatry. 67: 1159-60. PMID 16889466 DOI: 10.4088/Jcp.V67N0721F  0.397
2006 Garriock HA, Delgado P, Kling MA, Carpenter LL, Burke M, Burke WJ, Schwartz T, Marangell LB, Husain M, Erickson RP, Moreno FA. Number of risk genotypes is a risk factor for major depressive disorder: a case control study. Behavioral and Brain Functions : Bbf. 2: 24. PMID 16822313 DOI: 10.1186/1744-9081-2-24  0.451
2006 Tyrka AR, Price LH, Mello MF, Mello AF, Carpenter LL. Psychotic major depression: a benefit-risk assessment of treatment options. Drug Safety. 29: 491-508. PMID 16752932 DOI: 10.2165/00002018-200629060-00003  0.448
2006 Carpenter LL, Friehs GM, Tyrka AR, Rasmussen S, Price LH, Greenberg BD. Vagus nerve stimulation and deep brain stimulation for treatment resistant depression. Medicine and Health, Rhode Island. 89: 137, 140-1. PMID 16676910  0.338
2006 Carpenter LL. Neurostimulation in resistant depression. Journal of Psychopharmacology (Oxford, England). 20: 35-40. PMID 16644770 DOI: 10.1177/1359786806064327  0.424
2006 Geracioti TD, Carpenter LL, Owens MJ, Baker DG, Ekhator NN, Horn PS, Strawn JR, Sanacora G, Kinkead B, Price LH, Nemeroff CB. Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression. The American Journal of Psychiatry. 163: 637-43. PMID 16585438 DOI: 10.1176/Ajp.2006.163.4.637  0.405
2006 Carpenter LL, Schecter JM, Tyrka AR, Mello AF, Mello MF, Haggarty R, Price LH. Open-label tiagabine monotherapy for major depressive disorder with anxiety. The Journal of Clinical Psychiatry. 67: 66-71. PMID 16426090 DOI: 10.4088/Jcp.V67N0110  0.454
2005 Carpenter LL, Milosavljevic N, Schecter JM, Tyrka AR, Price LH. Augmentation with open-label atomoxetine for partial or nonresponse to antidepressants. The Journal of Clinical Psychiatry. 66: 1234-8. PMID 16259536 DOI: 10.4088/Jcp.V66N1005  0.428
2005 George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM, Howland R, Kling MA, Moreno F, Rittberg B, Dunner D, Schwartz T, Carpenter L, Burke M, Ninan P, et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biological Psychiatry. 58: 364-73. PMID 16139582 DOI: 10.1016/J.Biopsych.2005.07.028  0.381
2005 Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, Lavori P, Howland R, Kling MA, Rittberg B, Carpenter L, Ninan P, Moreno F, Schwartz T, Conway C, et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biological Psychiatry. 58: 355-63. PMID 16139581 DOI: 10.1016/J.Biopsych.2005.05.024  0.445
2004 Tyrka AR, Carpenter LL, McDougle CJ, Kirwin PD, Owens MJ, Nemeroff CB, Strong DR, Price LH. Increased cerebrospinal fluid corticotropin-releasing factor concentrations during tryptophan depletion in healthy adults. Biological Psychiatry. 56: 531-4. PMID 15450791 DOI: 10.1016/J.Biopsych.2004.06.035  0.309
2004 Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Biological Psychiatry. 56: 418-26. PMID 15364040 DOI: 10.1016/J.Biopsych.2004.06.025  0.384
2004 Carpenter LL, Heninger GR, Malison RT, Tyrka AR, Price LH. Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression. Journal of Affective Disorders. 79: 285-9. PMID 15023509 DOI: 10.1016/S0165-0327(02)00460-3  0.401
2004 Carpenter LL, Tyrka AR, McDougle CJ, Malison RT, Owens MJ, Nemeroff CB, Price LH. Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 777-84. PMID 14702025 DOI: 10.1038/Sj.Npp.1300375  0.445
2003 Mello AF, Mello MF, Carpenter LL, Price LH. Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 25: 231-8. PMID 15328550 DOI: 10.1590/S1516-44462003000400010  0.454
2003 Carpenter LL, Friehs GM, Price LH. Cervical vagus nerve stimulation for treatment-resistant depression. Neurosurgery Clinics of North America. 14: 275-82. PMID 12856494 DOI: 10.1016/S1042-3680(02)00121-3  0.435
2003 Greenberg BD, Price LH, Rauch SL, Friehs G, Noren G, Malone D, Carpenter LL, Rezai AR, Rasmussen SA. Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. Neurosurgery Clinics of North America. 14: 199-212. PMID 12856488 DOI: 10.1016/S1042-3680(03)00005-6  0.422
2002 Carpenter LL, Heninger GR, McDougle CJ, Tyrka AR, Epperson CN, Price LH. Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania. Psychiatry Research. 112: 257-62. PMID 12450635 DOI: 10.1016/S0165-1781(02)00233-0  0.314
2002 Carpenter LL, Leon Z, Yasmin S, Price LH. Do obese depressed patients respond to topiramate? A retrospective chart review. Journal of Affective Disorders. 69: 251-5. PMID 12103474 DOI: 10.1016/S0165-0327(01)00337-8  0.413
2002 Cubells JF, Price LH, Meyers BS, Anderson GM, Zabetian CP, Alexopoulos GS, Nelson JC, Sanacora G, Kirwin P, Carpenter L, Malison RT, Gelernter J. Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression. Biological Psychiatry. 51: 358-64. PMID 11904129 DOI: 10.1016/S0006-3223(01)01349-X  0.309
2002 Carpenter LL, Yasmin S, Price LH. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine. Biological Psychiatry. 51: 183-8. PMID 11822997 DOI: 10.1016/S0006-3223(01)01262-8  0.391
2001 Yasmin S, Carpenter LL, Leon Z, Siniscalchi JM, Price LH. Adjunctive gabapentin in treatment-resistant depression: a retrospective chart review. Journal of Affective Disorders. 63: 243-7. PMID 11246103 DOI: 10.1016/S0165-0327(00)00187-7  0.456
2000 Gagné GG, Furman MJ, Carpenter LL, Price LH. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. The American Journal of Psychiatry. 157: 1960-5. PMID 11097961 DOI: 10.1176/Appi.Ajp.157.12.1960  0.405
2000 Carpenter LL, Price LH. Psychotic depression: what is it and how should we treat it? Harvard Review of Psychiatry. 8: 40-2. PMID 10824297 DOI: 10.3109/Hrp.8.1.40  0.465
2000 Carpenter LL, Price LH. Psychotic Depression: What Is It and How Should We Treat It? Harvard Review of Psychiatry. 8: 40-42. DOI: 10.3109/hrp.8.1.40  0.301
1999 Malison RT, Anand A, Pelton GH, Kirwin P, Carpenter L, McDougle CJ, Heninger GR, Price LH. Limited efficacy of ketoconazole in treatment-refractory major depression. Journal of Clinical Psychopharmacology. 19: 466-70. PMID 10505589 DOI: 10.1097/00004714-199910000-00011  0.444
1999 Longhurst JG, Carpenter LL, Epperson CN, Price LH, McDougle CJ. Effects of catecholamine depletion with AMPT (alpha-methyl-para-tyrosine) in obsessive-compulsive disorder. Biological Psychiatry. 46: 573-6. PMID 10459409 DOI: 10.1016/S0006-3223(99)00019-0  0.373
1999 Carpenter LL, Leon Z, Yasmin S, Price LH. Clinical experience with mirtazapine in the treatment of panic disorder. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 11: 81-6. PMID 10440525 DOI: 10.1023/A:1022394415585  0.39
1999 Carpenter LL, Jocic Z, Hall JM, Rasmussen SA, Price LH. Mirtazapine augmentation in the treatment of refractory depression. The Journal of Clinical Psychiatry. 60: 45-9. PMID 10074878 DOI: 10.4088/Jcp.V60N0110  0.432
1998 Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, Sanacora G, Owens MJ, Nemeroff CB, Rajeevan N, Baldwin RM, Seibyl JP, Innis RB, Charney DS. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biological Psychiatry. 44: 1090-8. PMID 9836013 DOI: 10.1016/S0006-3223(98)00272-8  0.362
1996 Carpenter LL, McDougle CJ, Epperson CN, Price LH. A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder. Drug Safety. 15: 116-34. PMID 8884163 DOI: 10.2165/00002018-199615020-00004  0.318
1991 Prien RF, Carpenter LL, Kupfer DJ. The definition and operational criteria for treatment outcome of major depressive disorder. A review of the current research literature. Archives of General Psychiatry. 48: 796-800. PMID 1929769 DOI: 10.1001/Archpsyc.1991.01810330020003  0.408
1990 Bulik CM, Carpenter LL, Kupfer DJ, Frank E. Features associated with suicide attempts in recurrent major depression. Journal of Affective Disorders. 18: 29-37. PMID 2136867 DOI: 10.1016/0165-0327(90)90114-N  0.4
1989 Kupfer DJ, Frank E, Carpenter LL, Neiswanger K. Family history in recurrent depression. Journal of Affective Disorders. 17: 113-9. PMID 2527886 DOI: 10.1016/0165-0327(89)90033-5  0.398
1988 Kupfer DJ, Carpenter LL, Frank E. Possible role of antidepressants in precipitating mania and hypomania in recurrent depression. The American Journal of Psychiatry. 145: 804-8. PMID 3381922  0.314
1988 Kupfer DJ, Carpenter LL, Frank E. Is bipolar II a unique disorder? Comprehensive Psychiatry. 29: 228-36. PMID 3378412 DOI: 10.1016/0010-440X(88)90046-6  0.405
1988 Frank E, Carpenter LL, Kupfer DJ. Sex differences in recurrent depression: are there any that are significant? The American Journal of Psychiatry. 145: 41-5. PMID 3337291 DOI: 10.1176/Ajp.145.1.41  0.396
1987 Jacob M, Frank E, Kupfer DJ, Cornes C, Carpenter LL. A psychoeducational workshop for depressed patients, family, and friends: description and evaluation. Hospital & Community Psychiatry. 38: 968-72. PMID 3679103 DOI: 10.1176/Ps.38.9.968  0.398
1986 Carpenter LL, Kupfer DJ, Frank E. Is diurnal variation a meaningful symptom in unipolar depression? Journal of Affective Disorders. 11: 255-64. PMID 2951413 DOI: 10.1016/0165-0327(86)90077-7  0.406
Show low-probability matches.